Centennial Surgical Suture Inc
Fundamental Score
Centennial Surgical Suture Inc Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of CSURGSU across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Below-Average Return on Equity (-4.64%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.94%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Profit Decline Concern (-107.69%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-5.68%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Limited Growth History (-0.77% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Interest Coverage (0.35x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Centennial Surgical Suture Inc
About CSURGSU
Business Overview
Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centilene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The company also provides cardiovascular sutures, which include centibond, centiiwax, centilene, and centsteel; and other medical devices that comprise centipunch, centcel, centiitape, centiiwax, centilene mesh, centipace, and centipled, as well as disposable surgical skin stapler. Centenial Surgical Suture Ltd. was incorporated in 1995 and is based in Thane, India.
Company Details
Key Leadership
CSURGSU Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Centennial Surgical Suture Inc (CSURGSU)?
As of 19 Jan 2026, 10:08 am IST, Centennial Surgical Suture Inc (CSURGSU) is currently trading at ₹95.80. The stock has a market capitalization of ₹38.05 (Cr).
Is CSURGSU share price Overvalued or Undervalued?
CSURGSU is currently trading at a P/E ratio of 0.00x, compared to the industry average of 47.87x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Centennial Surgical Suture Inc share price?
Key factors influencing CSURGSU's price include its quarterly earnings growth (Sales Growth: -5.68%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Centennial Surgical Suture Inc a good stock for long-term investment?
Centennial Surgical Suture Inc shows a 5-year Profit Growth of N/A% and an ROE of -4.64%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.35 before investing.
How does Centennial Surgical Suture Inc compare with its industry peers?
Centennial Surgical Suture Inc competes with major peers in the Medical Equipment & Supplies. Investors should compare CSURGSU's P/E of 0.00x and ROE of -4.64% against the industry averages to determine its competitive standing.
What is the P/E ratio of CSURGSU and what does it mean?
CSURGSU has a P/E ratio of N/Ax compared to the industry average of 47.87x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is CSURGSU performing according to Bull Run's analysis?
CSURGSU has a Bull Run fundamental score of 13.5/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does CSURGSU belong to?
CSURGSU operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Centennial Surgical Suture Inc.
What is Return on Equity (ROE) and why is it important for CSURGSU?
CSURGSU has an ROE of -4.64%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Centennial Surgical Suture Inc generates profits from shareholders' equity.
How is CSURGSU's debt-to-equity ratio and what does it indicate?
CSURGSU has a debt-to-equity ratio of 0.35, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is CSURGSU's dividend yield and is it a good dividend stock?
CSURGSU offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has CSURGSU grown over the past 5 years?
CSURGSU has achieved 5-year growth rates of: Sales Growth -0.77%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in CSURGSU and why does it matter?
Promoters hold 46.89% of CSURGSU shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is CSURGSU's market capitalization category?
CSURGSU has a market capitalization of ₹38 crores, placing it in the Small-cap category.
How volatile is CSURGSU stock?
CSURGSU has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for CSURGSU?
CSURGSU has a 52-week high of ₹N/A and low of ₹N/A.
What is CSURGSU's operating profit margin trend?
CSURGSU has a 5-year average Operating Profit Margin (OPM) of 10.71%, indicating the company's operational efficiency.
How is CSURGSU's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -5.68% and YoY Profit Growth of -107.69%.
What is the institutional holding pattern in CSURGSU?
CSURGSU has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.